Awarded
BH_NonClinical_Pharmacy_Car-T
Barts Health NHS Trust · NHS and health
In brief
Barts Health NHS Trust awarded medical supplies and healthcare work to Bristol-Myers Squibb Pharmaceuticals Limited.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells.
The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products
At the time of writing it is only offered at 8 sites across the UK.
The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order.
The price paid to the supplier with be capped at NICE / NHS England approved list prices.
Who won
| Winner | Value | Dates |
|---|---|---|
| Bristol-Myers Squibb Pharmaceuticals Limited (SME) | £2,100,000 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Transparency notice · UK5, notice 077086-2025
About the buyer
Barts Health NHS TrustLast 12 months
Procurements
17Awards
6Similar open tenders
All open medical supplies tenders- £1.6mestimated
- £1.6mestimated
- £6.86mframework ceiling
- £3.33mframework ceiling
From notice 077086-2025 on Find a Tender, first published 26 November 2025. We last checked for changes on 28 September 2026.